SCHEMBL25049540

SCHEMBL25049540

CN1CCC[C@@]2(C1)CC2(F)F

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.33
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22597885 1.00 USP2 (0.33) USP2CYP2C9CYP2C19
SCHEMBL16840965 0.86 DRD4 (0.33)
SCHEMBL25779425 0.81 USP2 (0.35) USP2CYP2C9
SCHEMBL18911537 0.75
SCHEMBL90089 0.73
SCHEMBL25051611 0.72 TSHR (0.33)
SCHEMBL23265545 0.72
SCHEMBL23265519 0.71
SCHEMBL22047433 0.71
SCHEMBL90162 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023018810-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2023-02-16 WO disclosed